# Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants

> **NCT01758913** · NA · COMPLETED · sponsor: **Taipei Medical University Hospital** · enrollment: 110 (actual)

## Conditions studied

- Patent Ductus Arteriosus

## Interventions

- **DRUG:** Ibuprofen

## Key facts

- **NCT ID:** NCT01758913
- **Lead sponsor:** Taipei Medical University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2013-01-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01758913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01758913, "Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01758913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*